Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Arvinas Inc (ARVN)

Arvinas Inc (ARVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Arvinas Inc 5 SCIENCE PARK 395 WINCHESTER AVE NEW HAVEN CT 06511 USA

www.arvinas.com P: 203-535-1456

Description:

Arvinas Inc. is a biopharmaceutical company for patients suffering from debilitating and life-threatening diseases. It engages in the discovery, development and commercialization of therapies to degrade disease-causing proteins. Arvinas Inc. is based in CT, United States.

Key Statistics

Overview:

Market Capitalization, $K 2,146,027
Enterprise Value, $K 1,829,627
Shares Outstanding, K 68,432
Annual Sales, $ 78,500 K
Annual Net Income, $ -367,300 K
Last Quarter Sales, $ 25,300 K
Last Quarter Net Income, $ -69,400 K
EBIT, $ -397,100 K
EBITDA, $ -405,700 K
60-Month Beta 1.95
% of Insider Shareholders 5.23%
% of Institutional Shareholders 95.19%
Float, K 64,853
% Float 94.77%
Short Volume Ratio 0.58

Growth:

1-Year Return 35.84%
3-Year Return -51.38%
5-Year Return 47.16%
5-Year Revenue Growth 448.18%
5-Year Earnings Growth 73.99%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.97 on 05/07/24
Latest Earnings Date 05/10/24
Earnings Per Share ttm -5.93
EPS Growth vs. Prev Qtr 61.66%
EPS Growth vs. Prev Year 37.01%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

ARVN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -64.79%
Return-on-Assets % -30.46%
Profit Margin % -467.90%
Debt/Equity 0.00
Price/Sales 27.52
Price/Cash Flow N/A
Price/Book 3.52
Book Value/Share 8.93
Interest Coverage -2.63
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar